Atlas Trials

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

Clinical trial NCT01836146 · COMPLETED

Trial details

NCT number
NCT01836146
Sponsor
Abbott Medical Devices
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HypertensionRenal Denervation
Start date
2013-04-01
Primary completion
2014-03-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.